You are the director of research for a drug company. The following list of candidate drugs is brought to you. Which is the most likely to be worth developing as a cancer chemotherapy agent? A drug that
a. interferes with cellular
respiration
b. causes cells to divide at a right
angle from their usual orientation
c. prevents sister chromatids from
separating at anaphase.
I believe that the answer could be a, but really undecided.
1 answer